- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02076932
Effects of Physical Training on Adipose Tissue Metabolism and Insulin Sensitivity in the Menopausal Transition Phase
May 31, 2016 updated by: Bente Merete Stallknecht, University of Copenhagen
A Training Intervention Study in Late Pre- and Early Postmenopausal Women Investigating the Changes in Adipose Tissue Metabolism and Peripheral Insulin Sensitivity
The purpose of this study is to determine if physical exercise reduces the adverse changes in adipose tissue metabolism and insulin sensitivity that occurs in women during the menopausal transition.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
43
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen N, Denmark, 2200
- Department og Biomedical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 57 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Premenopausal OR Postmenopausal (45-57 years)
- No chronical Diseases
- BMI > 18,5 and < 30
- Sedentary (no regular physical activity the last 2 years)
- Either regular bleeding (premenopausal) OR no menstruation for at least 2 years (postmenopausal)
- Plasma measurements:
Premenopausal: estradiol > 0.20nmol/l, Follicle Stimulating Hormone < 22 IU/l and progesterone > 2.5 nmol/l Postmenopausal: estradiol < 0.20nmol/l, Follicle Stimulating Hormone > 22 IU/l and progesterone from 0.3-2.5 nmol/l
Exclusion Criteria:
- Smoking
- Excessive alcohol intake
- Regular medication including hormone replacement treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Premenopausal women
The premenopausal women will be attending Spinning classes.
|
After the baseline studies, the women will perform Spinning three times a week.
Two of the sessions are performed on our location by trained instructors and the third training is self-training in a local fitness center where we provide free membership.
All trainings are heart rate monitored.
|
|
Experimental: Postmenopausal Women
The postmenopausal women will be attending Spinning classes.
|
After the baseline studies, the women will perform Spinning three times a week.
Two of the sessions are performed on our location by trained instructors and the third training is self-training in a local fitness center where we provide free membership.
All trainings are heart rate monitored.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin stimulated uptake of glucose in adipose tissue
Time Frame: Baseline and 3 months
|
Measured by Positron Emission Tomography-Computed tomography (PET/CT)
|
Baseline and 3 months
|
|
Hyperinsulinemic euglycemic clamp
Time Frame: Baseline and 3 months
|
Glucose metabolized (mg/kg/min)
|
Baseline and 3 months
|
|
Adipose tissue distribution
Time Frame: Baseline and 3 months
|
Accessed by Magnetic Resonance Imaging (MRI).
|
Baseline and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Central insulin sensitivity
Time Frame: Baseline and 3 months
|
Fasting plasma insulin, homeostasis model assessment insulin resistance and measures of central insulin sensitivity derived from an oral glucose tolerance test
|
Baseline and 3 months
|
|
Maximal oxygen uptake (ml/O2/kg/min)
Time Frame: Baseline and 3 months
|
Measured using indirect calorimetry and an incremental bicycle protocol
|
Baseline and 3 months
|
|
Metabolic syndrome
Time Frame: Baseline and 3 months
|
As measured by high density lipoprotein, triglycerides, waist circumference, blood pressure, mean arterial pressure, fasting glucose and composite metabolic syndrome scores
|
Baseline and 3 months
|
|
Health related quality of life
Time Frame: Baseline and 3 months
|
Measured using questionaries, semi-structured interviews and observations
|
Baseline and 3 months
|
|
Anthropometry
Time Frame: Baseline and 3 months
|
Measured using dual x-ray absorptiometry, height, weight, waist and hip circumference, sagittal abdominal height
|
Baseline and 3 months
|
|
Skeletal muscle biopsy
Time Frame: Baseline and 3 months
|
Biochemical, proteomics, metabolomics, genomics and morphological analyses
|
Baseline and 3 months
|
|
Abdominal subcutaneous adipose tissue biopsy
Time Frame: Baseline and 3 months
|
Biochemical, proteomics, metabolomics, genomics and morphological analyses
|
Baseline and 3 months
|
|
Resting metabolic rate
Time Frame: Baseline and 3 months
|
Will be measured by indirect calorimetry
|
Baseline and 3 months
|
|
Physical activity level and duration of sleep
Time Frame: Baseline and 3 months
|
Daily activity and duration of sleep will be recorded during one week using Actibelt® and self reporting
|
Baseline and 3 months
|
|
Microdialysis
Time Frame: Baseline and 3 months
|
Adipose tissue microdialysis
|
Baseline and 3 months
|
|
Femoral subcutaneous adipose tissue biopsy
Time Frame: Baseline and 3 months
|
Biochemical, proteomics, metabolomics, genomics and morphological analyses
|
Baseline and 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary registration
Time Frame: Baseline and 3 months
|
Daily food intake for three week days and one week-end day will be reported by the subjects
|
Baseline and 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ylva Hellsten, Proff., University of Copenhagen
- Principal Investigator: Bente M Stallknecht, Proff. MD, University of Copenhagen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
January 1, 2016
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
February 24, 2014
First Submitted That Met QC Criteria
March 3, 2014
First Posted (Estimate)
March 4, 2014
Study Record Updates
Last Update Posted (Estimate)
June 1, 2016
Last Update Submitted That Met QC Criteria
May 31, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CWS menopause, adipose tissue
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEndoplasmic Reticulum Stress | HIV Related Insulin Resistance | Protease Inhibitor Related Insulin ResistanceUnited States
-
German Diabetes CenterYale UniversityRecruiting
-
National Institute of Diabetes and Digestive and...Active, not recruitingSevere Insulin ResistanceUnited States
-
Paloma Almeda-ValdésCompleted
-
Société des Produits Nestlé (SPN)CompletedInsulin Sensitivity/ResistanceSwitzerland
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
National Taiwan UniversityNational Cheng-Kung University HospitalCompletedExercise, Insulin Resistance, Visceral Adipose TissueTaiwan
-
University of CopenhagenNovo Nordisk A/S; Queen Mary University of London; University of SydneyNot yet recruitingInsulin Sensitivity/Resistance | Metabolic HealthDenmark
-
Assiut UniversityCompleted
-
University Health Network, TorontoCompletedInsulin Resistance Syndrome X | Pancreatic Beta Cell FunctionCanada
Clinical Trials on Spinning
-
University of CopenhagenRigshospitalet, Denmark; Glostrup University Hospital, CopenhagenCompletedCardiovascular Diseases | Metabolic Diseases | Blood Platelet Disorders | Menopause | Cardiac Function ImpairedDenmark
-
Premier HealthDartmouth-Hitchcock Medical Center; Parkinson's Disease FoundationCompletedParkinson DiseaseUnited States
-
Poznan University of Physical EducationPoznan University of Medical SciencesCompletedHypertension | Obesity | Dyslipidemias | Type 2 Diabetes | Endothelial DysfunctionPoland
-
Somogy Megyei Kaposi Mór Teaching HospitalCompletedMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Primary ProgressiveHungary
-
Dartmouth-Hitchcock Medical CenterParkinson's Disease FoundationTerminatedParkinson's DiseaseUnited States
-
University Hospital, Strasbourg, FranceUnknown